Collegium Pharmaceutical (COLL) Receivables (2016 - 2026)
Collegium Pharmaceutical's Receivables came in at $285.1 million for Q2 2026, up 33.8% from $213.02 million a year earlier and up 24.6% from the prior quarter.
Collegium Pharmaceutical (COLL) Receivables (2016 - 2026) Analysis & Trends
At the end of FY2025, Collegium Pharmaceutical's Receivables was $211.33 million, down 7.5% from FY2024.
- Receivables carries a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
- Going back by year, Receivables was $228.54 million in FY2024 (+27.3%), $179.53 million in FY2023 (-2.0%), $183.12 million in FY2022 (+73.0%) and $105.84 million in FY2021 (+27.0%).
- The Q2 2026 figure represents the highest quarterly Receivables in data going back to Q2 2016.
- Year-over-year, Receivables increased in six of the last eight quarters, with growth averaging 16.1%.
- The fastest year-over-year change in Receivables over five years came in Q2 2022 (growth of 119.2%), and the weakest in Q2 2023 (a decline of 15.2%).
- Business Quant data shows COLL's Receivables at $228.76 million (Q1 2026), $211.33 million (Q4 2025) and $233.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Collegium Pharmaceutical | 735.44 Mn | -488.33 Mn | 110.29 Mn | 285.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 285.10 Mn |
| Mar 31, 2026 | 228.76 Mn |
| Dec 31, 2025 | 211.33 Mn |
| Sep 30, 2025 | 233.95 Mn |
| Jun 30, 2025 | 213.02 Mn |
| Mar 31, 2025 | 228.71 Mn |
| Dec 31, 2024 | 228.54 Mn |
| Sep 30, 2024 | 228.46 Mn |
| Jun 30, 2024 | 183.86 Mn |
| Mar 31, 2024 | 174.69 Mn |
| Dec 31, 2023 | 179.53 Mn |
| Sep 30, 2023 | 181.85 Mn |
| Jun 30, 2023 | 167.48 Mn |
| Mar 31, 2023 | 179.13 Mn |
| Dec 31, 2022 | 183.12 Mn |
| Sep 30, 2022 | 195.40 Mn |
| Jun 30, 2022 | 197.51 Mn |
| Mar 31, 2022 | 166.35 Mn |
| Dec 31, 2021 | 105.84 Mn |
| Sep 30, 2021 | 149.00 Mn |
Collegium Pharmaceutical Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=COLL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();